What caused the infant-formula recalls in Europe?

Contamination concerns and regulatory probes

A wave of infant-formula withdrawals across Europe was prompted by detections of a toxin called cereulide in certain products, a development that triggered large-scale recalls and intense oversight. European regulators assessed the likely exposure for infants and reported that the risk from the identified contamination was low, but the scale of the recalls prompted criminal and regulatory inquiries.

Where investigations are focused:

• Contamination source: Authorities are trying to trace how cereulide — a toxin produced by some strains of Bacillus cereus — entered finished formula products and which manufacturing or supply-step failures allowed it to persist.
• Corporate accountability: Prosecutors in France opened inquiries that include major dairy and infant‑food manufacturers; the investigation could lead to fines or other sanctions depending on findings.
• Broader product checks: Other jurisdictions expanded testing and, in some cases, recalled separate batches or brands as a precaution while supply chains were audited.

Wider repercussions and consumer guidance

The recalls unsettled parents and disrupted some local supplies, prompting retailers and health agencies to issue guidance on safe alternatives and on how to register for recall notices. Separately, regulators in Brazil and elsewhere flagged unrelated formula issues — for example, concerns over iodine and selenium levels in some products — showing that the sector is facing multiple safety and compliance pressures.

What to expect next

Probes will continue into how contamination passed quality controls and whether industry procedures require systemic change. In the short term, parents are advised to follow official recall notices and health‑authority guidance; longer term, the industry can be expected to strengthen testing, supplier oversight, and traceability.